Consolidated Statements of Cash Flows (Unaudited) (USD $)	6 Months Ended
	Mar. 30, 2013	Mar. 31, 2012
Operating activities:
Net income	$ 2,597,446	$ 2,949,966
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	635,518	566,157
Provision for losses on accounts receivable	9,154	(3,000)
Increase in cash value of life insurance	(99,453)	(162,740)
Deferred compensation	(29,541)	(26,301)
Stock compensation expense	20,923	36,132
Changes in operating assets and liabilities:
Accounts receivable	(478,263)	(4,266,489)
Inventories	2,645,185	2,496,888
Prepaid expenses and other assets	(106,189)	10,656
Accounts payable and accrued expenses	(1,411,271)	(420,068)
Net cash provided by operating activities	3,783,509	1,181,201
Investing activities:
Acquisition of M.C. Healthcare		(8,251,831)
Proceeds from sale of securities available for sale		4,000,000
Purchases of property and equipment	(220,473)	(584,644)
Payments for other assets	(63,151)	(61,644)
Net cash used for investing activities	(283,624)	(4,898,119)
Financing activities:
Proceeds of long-term debt		8,800,000
Repayment of long-term debt		(6,000,000)
Dividends paid	(3,657,057)	(628,612)
Common stock issued upon exercise of options	147,665	68,946
Net cash (used for) provided by financing activities	(3,509,392)	2,240,334
Effect of exchange rates on cash	(79,718)	10
Decrease in cash and cash equivalents	(89,225)	(1,476,574)
Cash and cash equivalents at beginning of period	2,665,302	2,124,406
Cash and cash equivalents at end of period	$ 2,576,077	$ 647,832